Leadership change at AbelsonTaylor: Marti Sivesind, Media Strategy Role

AbelsonTaylor, a Chicago-based healthcare advertising agency, appointed Marti Sivesind to a newly created media strategy role, signaling a deliberate investment in strengthening its media planning and strategy capabilities. Sivesind brings experience in media strategy and planning, and her appointment reflects the agency's intent to deepen its expertise in navigating the increasingly complex healthcare media landscape. The creation of a new role rather than a backfill suggests AbelsonTaylor is expanding its organizational structure to meet growing client demand for sophisticated media strategy services. AbelsonTaylor has long been recognized as one of the leading independent healthcare advertising agencies in the United States, serving pharmaceutical, biotech, and medical device clients. The addition of a dedicated media strategy leadership position aligns with broader industry trends in which healthcare advertisers are demanding more integrated, data-driven media approaches — particularly as digital channels, programmatic buying, and direct-to-consumer pharmaceutical advertising continue to evolve. This move positions the agency to offer more holistic counsel to clients navigating regulatory constraints alongside modern media complexity. The appointment is notable within the healthcare AdTech and agency ecosystem because it underscores the growing importance of media strategy as a distinct discipline within specialized agencies. As healthcare brands increasingly invest in digital, CTV, and addressable media channels, having dedicated strategic leadership to guide media investment decisions is becoming a competitive differentiator for agencies competing for pharmaceutical and healthcare accounts.

This leadership appointment reflects a broader trend of healthcare-focused agencies investing in media strategy infrastructure as the pharmaceutical and healthcare advertising sector becomes more digitally sophisticated. The move signals that AbelsonTaylor is positioning itself to compete more aggressively for clients who require integrated media strategy alongside creative services, a capability gap that has historically driven healthcare brands toward larger holding company agencies. By elevating media strategy to a named leadership role, AbelsonTaylor may attract clients seeking independent agency agility combined with enterprise-level media thinking. Within the AdTech ecosystem, this development highlights continued demand for media strategy talent with healthcare expertise — a niche skill set given the regulatory environment governing pharmaceutical advertising, including FDA guidelines and HIPAA-adjacent data considerations. The appointment may also signal increased investment in programmatic, CTV, and data-driven targeting capabilities tailored to healthcare audiences, areas where specialized agencies have historically lagged behind their holding company counterparts.